Sort
50,496 grants matching “lung cancer”
Studies of the SARS-CoV-2 Spike Protein
$512,699Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Nonlinear performance analysis and prediction for robust low dose lung CT
$512,567Jianan Grace Gang · Johns Hopkins University · R01 · FY2021 · CA
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma
$512,562Keith D Robertson · Mayo Clinic Rochester · R01 · FY2024 · CA
Epidemiology and Natural History of Cancer-Associated Viruses
$512,551Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Cancer Bioinformatics Services
$512,508Riyue Bao · University Of Pittsburgh At Pittsburgh · P30 · FY2022 · CA
Cancer Bioinformatics Services
$512,508Riyue Bao · University Of Pittsburgh At Pittsburgh · P30 · FY2024 · CA
Cancer Bioinformatics Services
$512,508Riyue Bao · University Of Pittsburgh At Pittsburgh · P30 · FY2023 · CA
Steroid Hormones, Adipose-cytokines, and Diabetes Risk
$512,460Simin Liu · University Of California Los Angeles · R01 · FY2008 · DK
Faith Moves Mountains: A CBPR Appalachian Wellness & Cancer Prevention Program
$512,445Nancy E Schoenberg · University Of Kentucky · R24 · FY2011 · MD
TAS:: 75 0872:: TAS LUNG TISSUE RESEACH CONSORTIUM CLINICAL CENTER
$512,409Gerard J Criner · Temple Univ Of The Commonwealth · N01 · FY2012 · HL
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
$512,366Alexander Sparreboom · Ohio State University · R01 · FY2020 · CA
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
$512,366Alexander Sparreboom · Ohio State University · R01 · FY2021 · CA
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor
$512,284Hua Zhao · Virginia Commonwealth University · U01 · FY2022 · CA
Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
$512,266Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Multiplexed Nanosensing for DNA and Proteins
$512,260Richard James Cote · University Of Miami School Of Medicine · R01 · FY2008 · EB
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
$512,243Kwok Kin Wong · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
$512,243Kwok Kin Wong · Dana-Farber Cancer Inst · R01 · FY2015 · CA
TARGETING KRAS MUTANT LUNG CANCERS USING NOVEL BIOLOGICS
$512,241The Medical University Of South Carolina · · FY2025 · Defense Health Agency
miR-155 targeted therapeutics for precision medicine in lung cancer
$512,231George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
miR-155 targeted therapeutics for precision medicine in lung cancer
$512,229George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$512,222Bin Zhang · Northwestern University At Chicago · R01 · FY2024 · CA
Project 2: Functional Genetic Networks for Systems-Guided Precision Medicine
$512,053Stephanie Irene Fraley · University Of California, San Francisco · U54 · FY2022 · CA
Tailored Screening for Urinary System Cancers in Patients with Chronic Kidney Disease
$511,992Stella Kang · New York University School Of Medicine · R01 · FY2022 · CA
Phenotype Transitions in Small Cell Lung Cancer
$511,899Vito Quaranta · Vanderbilt University · U01 · FY2017 · CA
Phenotype Transitions in Small Cell Lung Cancer
$511,899Vito Quaranta · Vanderbilt University · U01 · FY2021 · CA